Drug intelligence / Profile preview

Polvac

Development stage
Unknown
Lead developer
Allergy Therapeutics
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

Polvac is a prominent brand of veterinary vaccines primarily developed and marketed by Zoetis (formerly Pfizer Animal Health). The product line encompasses a wide range of inactivated bacterial vaccines (bacterins) and toxoids designed to protect livestock and poultry against various infectious diseases. Key products within the line include Polvac C, which targets *Clostridium chauvoei* (Blackleg); Polvac S, an inactivated vaccine for *Salmonella typhimurium* and *Salmonella enteritidis* in poultry; and Polvac 7-in-1, a combination vaccine for cattle providing protection against five clostridial species and two *Leptospira* serovars. The mechanism of action involves the presentation of inactivated bacterial antigens or toxoids to the animal's immune system, stimulating the production of specific antibodies and memory cells to provide active immunity against subsequent natural exposure. The brand is particularly well-established in the Australian and New Zealand agricultural markets.

Brand names
PolvacPolvac CPolvac SPolvac EryPolvac 7-in-1Polvac7-in-1Polvac-7-in-1Polvac BPolvac PPolvac LPolvac VPolvac EPolvac MPolvac HPolvac APolvac RPolvac TPolvac DPolvac FPolvac GPolvac KPolvac NPolvac OPolvac UPolvac WPolvac XPolvac YPolvac Z
Other names
Polvac Polyvalent VaccinePolvac Salmonella VaccinePolvac Erysipelas VaccinePolvac Blackleg Vaccine
02

Targets

mIgE (Membrane-bound immunoglobulin E)

Beyond the preview

Go deeper on Polvac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polvac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call